Drug administration safety label

Description

FIG. 1 is a top plan view of a drug administrative safety label of our new design,

FIG. 2 is a top plan view of an alternative embodiment of a drug administrative safety label of our new design,

FIG. 3 is a top plan view of an alternative embodiment of a drug administrative safety label of our new design,

FIG. 4 is a top plan view of an alternative embodiment of a drug administrative safety label of our new design,

FIG. 5 is a top plan view of an alternative embodiment of a drug administrative safety label of our new design,

FIG. 6 is a top plan view of an alternative embodiment of a drug administrative safety label of our new design,

FIG. 7 is a top plan view of an alternative embodiment of a drug administrative safety label of our new design,

FIG. 8 is a top plan view of an alternative embodiment of a drug administrative safety label of our new design,

FIG. 9 is a top plan view of an alternative embodiment of a drug administrative safety label of our new design; and,

FIG. 10 is a top plan view of an alternative embodiment of a drug administrative safety label of our new design.

In the drawings, the broken lines represent environmental structure forming no part of the claimed design.

Claims

CLAIM The ornamental design for drug administration safety label, as shown and described.

---

Inventors:	Langan; Amy E. (Glenview, IL), Kruzynski; Richard J. (Long Grove, IL), Kollar; John A. (Northbrook, IL), Miyake; Patricia L. (Mundelein, IL), Kruk; Monique L. (Burlington, WI), Wagner; Mark F. (Gurnee, IL)
Assignee:	PharMEDium Services, LLC (Lake Forest, IL)
Appl. No.:	D/298,328
Filed:	December 3, 2007

---

Current U.S. Class:	D20/27
Current International Class:	1908
Field of Search:	;D20/10,11,13,22-24,27,99 ;40/124.01,124.02,124.04,299.01,310,325,360,326,538,541,584,594,600,630,638 ;206/63.3,534 ;283/56,71,81 ;428/40.1,40.2,42.3,914

---

References Cited [Referenced By]

---

U.S. Patent Documents

4065343	December 1977	Stumpe
D311423	October 1990	DeSantis
D386212	November 1997	Lambert
5924561	July 1999	Baumgartner et al.
D432176	October 2000	Stevens et al.
6568530	May 2003	Takahashi et al.
D522065	May 2006	Greenstein
D550287	September 2007	Smart et al.
7311205	December 2007	Adler et al.
2007/0029788	February 2007	Adler
2007/0252378	November 2007	Chambers

Other References

Syringe label for Atropine sulfate, known prior to Dec. 3, 2007, 1 page. cited by other . Label for alcohol preps, known prior to Dec. 3, 2007, 1 page. cited by other . IV bag label for 0.9% Sodium Chloride, known prior to Dec. 3, 2007, 1 page. cited by other . Syringe label for Labetalol Hydrochloride, known prior to Dec. 3, 2007, 1 page. cited by other . Label for drug vial for 0.9% Sodium Chloride, known prior to Dec. 3, 2007, 1 page. cited by other . Syringe label for Calcium Chloride, known prior to Dec. 3, 2007, 1 page. cited by other . Drug delivery device label for Phenylephrine, known prior to Dec. 3, 2007, 1 page. cited by other . Label for drug vial for Phenylephrine, known prior to Dec. 3, 2007, 1 page. cited by other . IV bag label for Fentanyl and Ropivacaine, known prior to Dec. 3, 2007, 1 page. cited by other . Label for drug vial for Vecuronium Bromide, known prior to Dec. 3, 2007, 1 page. cited by other.

Primary Examiner: Veynar; Caron
Assistant Examiner: Calabrese; Mary Ann
Attorney, Agent or Firm: Bell, Boyd & Lloyd LLP